CL2019003630A1 - Agente terapéutico contra la neumonía por aspiración, supuración pulmonar o absceso pulmonar. - Google Patents

Agente terapéutico contra la neumonía por aspiración, supuración pulmonar o absceso pulmonar.

Info

Publication number
CL2019003630A1
CL2019003630A1 CL2019003630A CL2019003630A CL2019003630A1 CL 2019003630 A1 CL2019003630 A1 CL 2019003630A1 CL 2019003630 A CL2019003630 A CL 2019003630A CL 2019003630 A CL2019003630 A CL 2019003630A CL 2019003630 A1 CL2019003630 A1 CL 2019003630A1
Authority
CL
Chile
Prior art keywords
therapeutic agent
agent against
aspiration pneumonia
lung abscess
pulmonary
Prior art date
Application number
CL2019003630A
Other languages
English (en)
Spanish (es)
Inventor
Masaaki Odajima
Sayoko Tanioka
Takaaki Sunouchi
Asako Tabuchi
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of CL2019003630A1 publication Critical patent/CL2019003630A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
CL2019003630A 2017-06-16 2019-12-11 Agente terapéutico contra la neumonía por aspiración, supuración pulmonar o absceso pulmonar. CL2019003630A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762520961P 2017-06-16 2017-06-16
JP2018068159 2018-03-30

Publications (1)

Publication Number Publication Date
CL2019003630A1 true CL2019003630A1 (es) 2020-07-10

Family

ID=66213244

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019003630A CL2019003630A1 (es) 2017-06-16 2019-12-11 Agente terapéutico contra la neumonía por aspiración, supuración pulmonar o absceso pulmonar.

Country Status (14)

Country Link
US (1) US20210137913A1 (https=)
EP (1) EP3639826A4 (https=)
JP (3) JP6618660B2 (https=)
KR (1) KR20200016960A (https=)
CN (1) CN110891571A (https=)
AU (1) AU2018283234A1 (https=)
BR (1) BR112019025960A2 (https=)
CA (1) CA3067188A1 (https=)
CL (1) CL2019003630A1 (https=)
IL (1) IL270831A (https=)
MX (1) MX2019014931A (https=)
PH (1) PH12019502835A1 (https=)
SG (1) SG11201911826VA (https=)
TW (1) TWI818910B (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
CN100410249C (zh) 2003-09-10 2008-08-13 杏林制药株式会社 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物
SA112330992B1 (ar) 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
WO2016148066A1 (ja) * 2015-03-13 2016-09-22 杏林製薬株式会社 呼吸器感染症治療剤
EP3305294A4 (en) * 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE

Also Published As

Publication number Publication date
KR20200016960A (ko) 2020-02-17
TW201906607A (zh) 2019-02-16
IL270831A (en) 2020-01-30
PH12019502835A1 (en) 2020-10-05
JP6671532B2 (ja) 2020-03-25
JP2020079330A (ja) 2020-05-28
AU2018283234A1 (en) 2019-12-12
MX2019014931A (es) 2020-02-13
US20210137913A1 (en) 2021-05-13
JP2020015769A (ja) 2020-01-30
EP3639826A4 (en) 2021-03-03
CN110891571A (zh) 2020-03-17
JPWO2018230686A1 (ja) 2019-12-12
JP6618660B2 (ja) 2019-12-11
EP3639826A1 (en) 2020-04-22
TWI818910B (zh) 2023-10-21
JP7098671B2 (ja) 2022-07-11
CA3067188A1 (en) 2018-12-20
SG11201911826VA (en) 2020-01-30
BR112019025960A2 (pt) 2020-11-03

Similar Documents

Publication Publication Date Title
CY1121928T1 (el) Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης
BR112014017749A8 (pt) Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
PH12015502013A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
DOP2019000275A (es) Nuevos derivados de pirazol bicíclicos
MX364942B (es) Peptidos antimicrobianos.
MX2015016971A (es) Formulacion que comprende un agente hipolipidemico.
BR112018001435A2 (pt) métodos para entrega linfática de agentes ativos
MX383032B (es) Formulaciones farmaceuticas inyectables de lefamulina.
MX386107B (es) Composiciones para el cuidado bucal.
JOP20170127A1 (ar) صيغة مشتركة مكونة من ثلاث مركبات مضادة للفيروسات
CL2019003630A1 (es) Agente terapéutico contra la neumonía por aspiración, supuración pulmonar o absceso pulmonar.
BR112017019205A2 (pt) agente de tratamento de infecção respiratória
EA201890789A1 (ru) Содержащая цинеол композиция для лечения заболеваний носа
CL2020003153A1 (es) Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016)
UY36183A (es) Métodos para tratar infecciones
MY200429A (en) Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess
CR20160591A (es) Metodos para tratar infecciones